Autor: |
Reijerkerk A; Blood-Brain Barrier Research Group, Molecular Cell Biology and Immunology, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands., Lopez-Ramirez MA, van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, Vos JB, van der Pouw Kraan TC, van Zonneveld AJ, Horrevoets AJ, Prat A, Romero IA, de Vries HE |
Jazyk: |
angličtina |
Zdroj: |
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2013 Apr 17; Vol. 33 (16), pp. 6857-63. |
DOI: |
10.1523/JNEUROSCI.3965-12.2013 |
Abstrakt: |
Blood-brain barrier (BBB) dysfunction is a major hallmark of many neurological diseases, including multiple sclerosis (MS). Using a genomics approach, we defined a microRNA signature that is diminished at the BBB of MS patients. In particular, miR-125a-5p is a key regulator of brain endothelial tightness and immune cell efflux. Our findings suggest that repair of a disturbed BBB through microRNAs may represent a novel avenue for effective treatment of MS. |
Databáze: |
MEDLINE |
Externí odkaz: |
|